Imaging scientists back MR to detect ductal carcinoma

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 11
Volume 31
Issue 11

MRI, possibly employing higher field strengths and dedicated breast coils, should be used more often for detecting ductal carcinoma in situ, according to a panel convened by the National Institutes of Health.

MRI, possibly employing higher field strengths and dedicated breast coils, should be used more often for detecting ductal carcinoma in situ, according to a panel convened by the National Institutes of Health.

MRI is used for adjunct screening in women at high risk, but could gain significance when diagnosing DCIS, according to a Sept. 24 statement issued by the panel. The experts recommended looking at how higher field strength magnets and dedicated breast coils might improve detection. They also called for comparative effectiveness studies in individuals who do and do not undergo MRI. The comments came in a conference sponsored by the NIH and the National Cancer Institute.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.